401 related articles for article (PubMed ID: 29283887)
1. Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression.
Bhome R; Goh RW; Bullock MD; Pillar N; Thirdborough SM; Mellone M; Mirnezami R; Galea D; Veselkov K; Gu Q; Underwood TJ; Primrose JN; De Wever O; Shomron N; Sayan AE; Mirnezami AH
Aging (Albany NY); 2017 Dec; 9(12):2666-2694. PubMed ID: 29283887
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer cell-derived exosomes containing miR-10b regulate fibroblast cells via the PI3K/Akt pathway.
Dai G; Yao X; Zhang Y; Gu J; Geng Y; Xue F; Zhang J
Bull Cancer; 2018 Apr; 105(4):336-349. PubMed ID: 29496262
[TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated transfer of miR-93-5p from cancer-associated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB3.
Chen X; Liu J; Zhang Q; Liu B; Cheng Y; Zhang Y; Sun Y; Ge H; Liu Y
J Exp Clin Cancer Res; 2020 Apr; 39(1):65. PubMed ID: 32293494
[TBL] [Abstract][Full Text] [Related]
4. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
5. microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2.
Xu Y; Shen L; Li F; Yang J; Wan X; Ouyang M
J Cell Physiol; 2019 Nov; 234(11):21380-21394. PubMed ID: 31102273
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts-derived exosomes upregulate microRNA-135b-5p to promote colorectal cancer cell growth and angiogenesis by inhibiting thioredoxin-interacting protein.
Yin H; Yu S; Xie Y; Dai X; Dong M; Sheng C; Hu J
Cell Signal; 2021 Aug; 84():110029. PubMed ID: 33932496
[TBL] [Abstract][Full Text] [Related]
8. Exosomal-miR-522-3p derived from cancer-associated fibroblasts accelerates tumor metastasis and angiogenesis via repression bone morphogenetic protein 5 in colorectal cancer.
Zhang J; Pan Y; Jin L; Yang H; Cao P
J Gastroenterol Hepatol; 2024 Jan; 39(1):107-120. PubMed ID: 37984826
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts-derived exosome-mediated transfer of miR-345-5p promotes the progression of colorectal cancer by targeting CDKN1A.
Shi W; Liu Y; Qiu X; Yang L; Lin G
Carcinogenesis; 2023 Jun; 44(4):317-327. PubMed ID: 37052230
[TBL] [Abstract][Full Text] [Related]
10. Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis.
Zhou L; Li J; Tang Y; Yang M
J Transl Med; 2021 Jan; 19(1):8. PubMed ID: 33407563
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
12. Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214/PD-L1 axis.
Yang K; Zhang J; Bao C
BMC Cancer; 2021 Aug; 21(1):933. PubMed ID: 34412616
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1.
Shang A; Wang X; Gu C; Liu W; Sun J; Zeng B; Chen C; Ji P; Wu J; Quan W; Yao Y; Wang W; Sun Z; Li D
Aging (Albany NY); 2020 May; 12(9):8352-8371. PubMed ID: 32364530
[TBL] [Abstract][Full Text] [Related]
14. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cell-Derived Exosomal microRNA-3940-5p Inhibits Colorectal Cancer Metastasis by Targeting Integrin α6.
Li T; Wan Y; Su Z; Li J; Han M; Zhou C
Dig Dis Sci; 2021 Jun; 66(6):1916-1927. PubMed ID: 32671583
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
[TBL] [Abstract][Full Text] [Related]
18. Profiling the MicroRNA Payload of Exosomes Derived from Ex Vivo Primary Colorectal Fibroblasts.
Bhome R; Goh R; Pickard K; Mellone M; Sayan AE; Mirnezami A
Methods Mol Biol; 2017; 1509():115-122. PubMed ID: 27826922
[TBL] [Abstract][Full Text] [Related]
19. Loss of exosomal miR-200b-3p from hypoxia cancer-associated fibroblasts promotes tumorigenesis and reduces sensitivity to 5-Flourouracil in colorectal cancer via upregulation of ZEB1 and E2F3.
Gong W; Guo Y; Yuan H; Chai R; Wan Z; Zheng B; Hu X; Chen B; Gao S; Dai Q; Yu P; Tu S
Cancer Gene Ther; 2023 Jun; 30(6):905-916. PubMed ID: 36890211
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression.
Yoshii S; Hayashi Y; Iijima H; Inoue T; Kimura K; Sakatani A; Nagai K; Fujinaga T; Hiyama S; Kodama T; Shinzaki S; Tsujii Y; Watabe K; Takehara T
Cancer Sci; 2019 Aug; 110(8):2396-2407. PubMed ID: 31148360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
